Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02510066 | Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain | unknown | Phase 3 | 62 | Shanghai Cancer Hospital, ChinaOTHER | 1 | Jul 28, 2015 | clinicaltrials |
| NCT02024633 | Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer | unknown | Phase 1 | 24 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT01879878 | Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial](POUDER) | unknown | N/A | 40 | Heidelberg UniversityOTHER | 1 | May 28, 2015 | clinicaltrials |
| NCT02278458 | Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer | unknown | Phase 1 | 24 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT02305914 | Follow-up Study of Complications of Acute Pancreatitis(FSCAP) | unknown | — | 1,300 | The First Affiliated Hospital of Nanchang UniversityOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT02424279 | Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder | unknown | N/A | 90 | Medical University of GdanskOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT01608841 | The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib | unknown | Phase 2 | 88 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Feb 18, 2015 | clinicaltrials |
| NCT02213419 | Endoscopic Ultrasonography-guided Double Ethanol Lavage for Pancreatic Cysts: a Prospective Cohort Study | unknown | Phase 1 | 40 | Samsung Medical CenterOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer(GIP-2) | unknown | Phase 3 | 310 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01898741 | Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 30 | UMC UtrechtOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT02327065 | Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion | unknown | N/A | 408 | Huazhong University of Science and TechnologyOTHER | 1 | Dec 30, 2014 | clinicaltrials |
| NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | unknown | Phase 2 / Phase 3 | 1 | Assiut UniversityOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01698190 | Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions | unknown | N/A | 400 | Stony Brook UniversityOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT02285660 | Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition | unknown | N/A | — | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT02260128 | Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery | unknown | N/A | 72 | Michael Bau MortensenOTHER | 1 | Oct 9, 2014 | clinicaltrials |
| NCT01411072 | Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer | unknown | N/A | 20 | AHS Cancer Control AlbertaOTHER | 1 | Oct 3, 2014 | clinicaltrials |
| NCT01586611 | A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer(Panc001) | unknown | Phase 3 | 175 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT02246322 | A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.(EUS-FNA) | unknown | N/A | 144 | Istituto Clinico HumanitasOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT02238613 | Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer | unknown | N/A | 140 | 307 Hospital of PLAOTHER | 1 | Sep 12, 2014 | clinicaltrials |
| NCT02209415 | EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer(EUFURO) | unknown | N/A | 182 | Michael Bau MortensenOTHER | 1 | Aug 5, 2014 | clinicaltrials |
| NCT02079363 | DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer | unknown | — | 330 | Aalborg University HospitalOTHER | 1 | Jul 30, 2014 | clinicaltrials |
| NCT02184871 | Next Generation Sequencing in Intrahepatic Cholangiocarcinoma(EtherBil) | unknown | — | 45 | University of BolognaOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT02178280 | Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT02135822 | Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer(NAPGAP) | unknown | Phase 2 | 30 | Chinese PLA General HospitalOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT02121366 | EUS-guided Ethanol Ablation of an Insulinoma(EUS) | unknown | N/A | 50 | Guangxi Medical UniversityOTHER | 1 | Apr 23, 2014 | clinicaltrials |
| NCT01381822 | Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors(TH-CR-410) | unknown | Phase 1 | 58 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 21, 2014 | clinicaltrials |
| NCT02103179 | VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)(VEGF ECC) | unknown | — | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 3, 2014 | clinicaltrials |
| NCT01065870 | Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) | unknown | Phase 2 / Phase 3 | 64 | Columbia UniversityOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT02042859 | Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer(EndoHPB) | unknown | Phase 1 | 40 | Ochsner Health SystemOTHER | 0 | Jan 23, 2014 | clinicaltrials |
| NCT02038738 | 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors | unknown | Phase 1 / Phase 2 | 250 | Ochsner Health SystemOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT01074996 | Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers(APC-S1) | unknown | Phase 2 | 92 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT01941342 | Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy | unknown | Phase 2 | 274 | Southwest Hospital, ChinaOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00003296 | Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer | unknown | Phase 2 | 26 | Brown UniversityOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003780 | Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | unknown | Phase 2 | 150 | Meyer PharmaceuticalsINDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003797 | Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas | unknown | Phase 2 | 41 | Brown UniversityOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00010270 | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | unknown | Phase 1 | 50 | University Hospital FreiburgOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT01659502 | Investigator's Initiated Phase II Study for Pancreatic Cancer Patients | unknown | Phase 2 | 10 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01994681 | Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air | unknown | — | 100 | Rauscher, Gregory E., M.D. PAINDIV | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00005869 | Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | unknown | Phase 3 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01978808 | Efficiency Study of the EUS-FNA Needles With and Without a Side Port in Pancreatic Masses | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Nov 13, 2013 | clinicaltrials |
| NCT00454376 | Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors | unknown | — | 408 | National Cancer Institute (NCI)NIH | 10 | Oct 29, 2013 | clinicaltrials |
| NCT01969110 | Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy | unknown | Phase 4 | 60 | Chiba UniversityOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT01942629 | Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas | unknown | — | 300 | Rambam Health Care CampusOTHER | 0 | Sep 16, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2015source: clinicaltrials